William D. Waddill, who is the SVP and CFO for Calithera Biosciences, has been elected to the Protagonist Therapeutics Inc. Board of Directors, Protagonist announced last week.
"We are very pleased to welcome Will Waddill to the Board of Directors of Protagonist," Dinesh Patel, CEO of Protagonist, said. "We look forward to benefiting from Will's financial leadership and experience within the biotechnology sector as Protagonist continues to grow as an organization."
For more than 30 years, Waddill has worked in corporate finance, banking and public accounting. Before he began his career with Calithera, he served as the SVP and the CFO for OncoMed Pharmaceuticals. Prior to joining OncoMed, Waddill worked at Ilypsa, where he was also the SVP and CFO. During his time at Ilypsa he served as the finance lead for its purchase by Amgen. Before his time with Ilypsa, he was a founder and a principal at Square One Finance.
Waddill earned his bachelor of science from the University of Illinois in accounting and was certified as a public accountant which is currently inactive.